| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/25/2007 | CN1312139C Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators |
| 04/25/2007 | CN1312138C Novel azoles having an insecticidal action |
| 04/25/2007 | CN1312137C 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 04/25/2007 | CN1312136C Triazole derivatives as tachykinin receptor antagonists |
| 04/25/2007 | CN1312135C Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic agents |
| 04/25/2007 | CN1312132C 1-benzyl tetrahydro isoquinoline compound, its preparing process and use thereof |
| 04/25/2007 | CN1312131C Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredent |
| 04/25/2007 | CN1312129C Polymorphs of donepezil hydrochloride and process for production |
| 04/25/2007 | CN1312128C Method for preparing 13 5-triaminobenzene and hydrolyzing it into high-purity phloroglucinal |
| 04/25/2007 | CN1312127C 2-cyano-4-fluoropyrrolidine derivative or its salt |
| 04/25/2007 | CN1312125C Amino alcohol derivative, addition salt thereof, and immunosuppressant |
| 04/25/2007 | CN1312121C Novel stable crystals of substituted phenylpropionic acid derivative and process for producing the same |
| 04/25/2007 | CN1312120C Adamantane derivatives |
| 04/25/2007 | CN1312116C Calcium acceptor active compound |
| 04/25/2007 | CN1312089C Eudesmane compounds, preparing method and use in preparing medicinal composition |
| 04/25/2007 | CN1311859C Adhesive umbilicus powder for removing spot |
| 04/25/2007 | CN1311858C Medicinal composition for treating cervical vertebra disease, its preparation method and application |
| 04/25/2007 | CN1311854C Medicinal composition for treating traumatic surface |
| 04/25/2007 | CN1311850C External use medicinal composition for treating swelling paint |
| 04/25/2007 | CN1311848C Externally applied medicine for treating tinea pedis |
| 04/25/2007 | CN1311846C Wet and thermophily Chinese herb medicinal liquid for treating burn and scald |
| 04/25/2007 | CN1311842C Medicine for treating chronic conjunctivitis and its preparing method |
| 04/25/2007 | CN1311841C Blood circulation promoting and pain alleviating soft capsule and its preparation |
| 04/25/2007 | CN1311840C Quick-acting liquid preparation for toothache |
| 04/25/2007 | CN1311836C Functional chewing gum composition for improving effectively obesity and blood fat |
| 04/25/2007 | CN1311835C Pharmaceutical parenteral composition containing biphosphonate |
| 04/25/2007 | CN1311834C Melanogenesis inhibitors and whitening agents comprising ergosterol derivatives and compositions containing ergosterol derivatives |
| 04/25/2007 | CN1311833C Inhibition of the growth factor dependency of tumor cells |
| 04/25/2007 | CN1311832C Medicinal use of bromodihydroarteannuin |
| 04/25/2007 | CN1311831C Antibacterial medicinal composition of enhanced oral absorptivity |
| 04/25/2007 | CN1311830C Cefadroxil oral disintegrant tablet, and its prepn. method |
| 04/25/2007 | CN1311829C Heteroaryl compounds which inhibit leukocyte adhesion mediated by alpha-4 integrins |
| 04/25/2007 | CN1311828C Use of CGMP phosphodiesterase inhibitor for treating sexual impotence |
| 04/25/2007 | CN1311827C 加替沙星软胶囊及其制备方法 Gatifloxacin soft capsule and its preparation method |
| 04/25/2007 | CN1311826C Nano composition of 9-nitrocamptothecin lipoid and its preparation |
| 04/25/2007 | CN1311825C Pioglitazone soft capsule and its preparing method |
| 04/25/2007 | CN1311824C Enteric coated micro particle preparation of omeprazole and its preparation method |
| 04/25/2007 | CN1311823C Indirubin phosphatide compound and its preparation method |
| 04/25/2007 | CN1311822C Preparation of slowly releasing silybum mariamum |
| 04/25/2007 | CN1311821C Nerve fiber regeneration accelerator |
| 04/25/2007 | CN1311820C Compsn. of medication of containing ketone ester of gingkgo and general salviol acid and its use |
| 04/25/2007 | CN1311819C Crystalline composition containing escitalopram |
| 04/25/2007 | CN1311818C Pharmaceutical composition for solid tumour |
| 04/25/2007 | CN1311817C Solid tumor treating medicine composition |
| 04/25/2007 | CN1311816C Gum of ambroxol hydrochloride and preparation thereof |
| 04/24/2007 | USRE39593 Diastereoisomers with an analgesic effect; suitable for the treatment of severe pain without the side effects of opioids |
| 04/24/2007 | USRE39592 Solid composition for implantation into an animal of 17 beta -acetoxyestra-4,9,11-trien-3-one and Estra-1,3,5(10)-trien-3,17 beta -diol with 75:25-DL-lactide-glycolide Copolymer; biodegradable polymer |
| 04/24/2007 | USRE39591 Macrolides with increased acid stability relative to erythromycin A and 6-O-methyl erythromycin A and enhanced activity toward gram negative bacteria and macrolide resistant gram positive bacteria |
| 04/24/2007 | USRE39585 Administering streptococcus thermophilus in admixture withLactobacillus brevis, Lactobacillus acidophilus, Lactobacillus plantarum, Bifidobacterium infantis, Bifidobacterium longum or Bifidobacterium breve |
| 04/24/2007 | US7208629 5′-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2007 | US7208628 Compositions and methods for the treatment of hepatitis C virus infection |
| 04/24/2007 | US7208623 Process for the manufacture of HMG-CoA reductase inhibitory mevalonic acid derivatives |
| 04/24/2007 | US7208616 Cis-diiodo-(trans-L-1,2-cyclohexanediamine) platinum (II) complex and processes for preparing high purity oxaliplatin |
| 04/24/2007 | US7208611 Diammine and bis(cyclohexanediamine) complexes of platinium malonates containing glucopyranosyl, mannopyranosyl, galactopyranosyl or glucurony groups [1R,2R-Cyclohexanediamine-N, N'][{2-( beta -D-Glucopyranos-1-ylamido)ethyl}propanedioato(2-)-O,O']Platinum(II); good water solubility |
| 04/24/2007 | US7208607 Reaction of 2-bromophenylalaninate with diisopropylethylamine and (2R)-2-bromopropionyl chloride and reaction of product with ethyl (2S)-2-aminopentanoate, triethylamine and acetonitrile, and hydrogenation of product; new process uses readily obtainable starting materials |
| 04/24/2007 | US7208602 N-sulfonyl- azetidines, pyrrolidines, piperidines and hexamethylenimines; treatment and prevention of Alzheimer's Disease and other diseases relating to the deposition of amyloid protein. |
| 04/24/2007 | US7208600 Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases |
| 04/24/2007 | US7208598 Trans-N2-(4-aminocyclohexyl)-N6-[2-[[[4-choro-3-trifluoromethyl)-phenyl]-methyl]-amino]-ethyl]-9-cyclopentyl-9H-purin-2,6-diamine trihydrochloride; cycline-dependent kinase proteins (cdk) inhibitor; animitotic, antitumor agents |
| 04/24/2007 | US7208596 Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof |
| 04/24/2007 | US7208594 mixture with polysorbate; beverages, cosmetics, nutrient adjuvants, cleaning compounds, |
| 04/24/2007 | US7208593 Self-cross-linked alkyl cellulose |
| 04/24/2007 | US7208528 Inhibititors of polyamine transport or other polyamine binding proteins; anticarcinogenic, antitumor, and antiproliferative agents; post-angioplasty injury |
| 04/24/2007 | US7208527 Potassium channel modulators |
| 04/24/2007 | US7208526 For example, (E)-2-(4-Chloro-phenyl)-ethenesulfonic acid 2,4-dichloro-benzoylamide; for use in the control or prevention of illnesses such as cancer; antitumor agents |
| 04/24/2007 | US7208525 Diagnostic agents for pancreatic exocrine function |
| 04/24/2007 | US7208524 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation |
| 04/24/2007 | US7208523 Slight toxicity and can be administered orally or intravenously to improve liver function |
| 04/24/2007 | US7208522 Methods and compositions for the prevention and treatment of Syndrome X |
| 04/24/2007 | US7208521 Selective inhibitors of the urokinase plasminogen activator |
| 04/24/2007 | US7208520 Crystals of hydroxynorephedrine derivative |
| 04/24/2007 | US7208518 antiinflammatory agents; asthma; 2-hydroxy-3-(4-hydroxy-5-methyl-2-oxo-2H-chromene-3-yl)-9-methyl-2,3-dihydro-4H-furo[3,2-c]chromene-4-one; from 4-Hydroxycoumarin and glyoxal |
| 04/24/2007 | US7208517 Treating nociception by administering to a mammal in need of such treatment a therapeutically effective amount of trans,trans-2-(4-methoxyphenyl)-4-(1,3-benzodioxol-5-yl)-1-(N,N-di(n-butyl)aminocarbonylmethyl)-pyrrolidine-3-carboxylic acid, or a pharmaceutically acceptable salt thereof |
| 04/24/2007 | US7208516 Treatment may include administration of a second active agent, including but not limited to, an anti-inflammatory agent, an immnunosuppressant, mycophenolate mofetil, a biologic agent, or a Cox-2 inhibitor |
| 04/24/2007 | US7208515 Diphenylmethyl compounds useful as muscarinic receptor antagonists |
| 04/24/2007 | US7208514 Phenylpyrazole compounds such as 1-(3-cyano-4-neopentyloxyphenyl)pyrazole-4-carboxylic acid and the like for preventing colon cancer and the like, and as an agent for suppressing tumorigenesis |
| 04/24/2007 | US7208513 Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith |
| 04/24/2007 | US7208512 Benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
| 04/24/2007 | US7208511 Microbicidal composition |
| 04/24/2007 | US7208509 Non-nucleoside reverse transcriptase inhibitors |
| 04/24/2007 | US7208508 Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations |
| 04/24/2007 | US7208507 Pyridines and uses thereof |
| 04/24/2007 | US7208506 Antiproliferative agent; antitumor, anticancer; 2-Thiophen-2-yl-ethenesulfonic acid benzoylamides; reaction of the halogenated heteroaryl ring with ethenesulfonic acid (1,1,3,3-tetramethyl-butyl)-amide, dealkylation, then benzoylation |
| 04/24/2007 | US7208505 Treating Type 2 diabetes and/or obesity; compounds are indoles substituted at position 3 with a (3-(2-(heterocycle-substituted)phenoxy)-2-hydroxypropylamino)alkyl group |
| 04/24/2007 | US7208504 Bicyclic inhibitors of hormone sensitive lipase |
| 04/24/2007 | US7208503 Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 04/24/2007 | US7208502 Methods of treating conditions associated with an Edg-3 receptor |
| 04/24/2007 | US7208501 Potent and long lasting antimuscarinic agents; respiratory, urological or gastrointestinal disorders |
| 04/24/2007 | US7208500 Treating hyperproliferative disorders; N-(4,6-Dimethyl-pyridin-2-yl)-2-{3-fluoro-4-[2-(1-methyl- 1H-imidazol-2-yl)-thieno[3,2-b]pyridin-7-yloxy]-phenyl}-acetamide for example; receptor kinase inhibitors |
| 04/24/2007 | US7208499 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 04/24/2007 | US7208498 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 04/24/2007 | US7208497 Substituted piperazines and diazepanes |
| 04/24/2007 | US7208496 Substituted heterocyclic compounds |
| 04/24/2007 | US7208495 Benzo-fused 5-membered hetrocycle compounds, process for preparation of the same, and use thereof |
| 04/24/2007 | US7208494 5HT2c receptor agonists |
| 04/24/2007 | US7208493 Vasculostatic agents and methods of use thereof |
| 04/24/2007 | US7208492 Topoisomerase-targeting agents |
| 04/24/2007 | US7208491 N-monoacylated o-phenylenediamines |
| 04/24/2007 | US7208490 Having useful antibacterial activity against a wide range of human and veterinary pathogens; for therapy of microbial infections in mammals |
| 04/24/2007 | US7208489 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones |
| 04/24/2007 | US7208488 Treating Alzheimer's Disease; 4-Chloro-N-(4-hydroxy-3-methoxy-benzyl)-N-(2-oxo-azepan-3-yl)-benzenesulfonamide for example; gamma secretase inhibitors; inhibition of beta-amyloid synthesis with minimal inhibition of Notch Signaling |